Elbit Imaging Ltd.
EMITF
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.25M
Close$
$-1.56
197.4% downside
Current Fair Value
197.4% downsideOvervalued by 197.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.25 Million |
|---|---|
| Enterprise Value | $230.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.38 |
| Beta | 0.29 |
| Outstanding Shares | 14,453,846 |
Return
| Return on Equity | -5.35% |
|---|---|
| Return on Assets | -1.17% |
| Return on Invested Capital | -0.36% |
Valuation & Multiples
| P/E Ratio | -12.27 |
|---|---|
| PEG | -25.15 |
| Price to Sales | 0.8 |
| Price to Book Ratio | 0.27 |
| Enterprise Value to Revenue | 6.01 |
| Enterprise Value to EBIT | -262.26 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 1.11 |
| Debt to Equity | 2.94 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Elbit Imaging Ltd.
3 employees
CEO: Mr. Ron Hadassi BA, LL.B, MBA Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asi...